5 Minutes with: Dr Katharine Rendle

Dr. Katharine A. Rendle, PhD, MPH is an Assistant Professor of Family Medicine & Community Health and of Epidemiology in the Perelman School of Medicine, and the Director of Implementation Science at the Penn Center for Cancer Care Innovation.

She is also the Associate Director of the Penn Implementation Science Center, the Associate Director of the Mixed Methods Research Lab, and a full member of the Abramson Cancer Center.

At Penn, Dr. Rendle leads a robust and growing research program that integrates diverse quantitative and qualitative methods to improve the quality, equity, and implementation of cancer care delivery, with a substantial focus in cervical and lung cancer. 

 

  1. When/where do you get your best research ideas?

Early in the morning with coffee

 

  1. Which failure changed you the most?

Grant rejections because they test my commitment to the area of research

 

  1. What is the best piece of advice (work or life) you’ve been given?

Be a boundary spanner

 

  1. I’m inspired most by…

My family

 

  1. What’s an event that changed your life?

Being an NCI Cancer Prevention Fellow

 

  1. What’s the next big thing in cancer? What will be the game changers?

Single/Multiple Cancer Early Detection Tests – figuring out first if they save more lives and how they can be implemented if they do

 

  1. What is your favourite paper that you’ve published in the last 5 years?

Evaluating Lung Cancer Screening Across Diverse Healthcare Systems: A Process Model from the Lung PROSPR Consortium

It has shaped how I think about lung cancer screening and the complexities that have to be tackled for it to be equitably implemented.

 

 

You can listen to Dr Rendle discussing lung cancer screening at the next CRUK and UKSBM Cancer SIG webinar on 6th December 2022 – sign up here!

About Jane Rigney 73 Articles
This post is written by Jane Rigney. Jane is a Clinical Project Manager in the Cancer Prevention Group. She oversees numerous projects, including cancer screening projects, our Patient and Public Involvement (PPI) and general communications.